![](/img/cover-not-exists.png)
Preclinical evaluation of VAX-IP, a novel bacterial minicell-based biopharmaceutical for nonmuscle invasive bladder cancer
Tsuji, Shingo, Chen, Xuguang, Hancock, Bryan, Hernandez, Veronica, Visentin, Barbara, Reil, Katherine, Sabbadini, Roger, Giacalone, Matthew, Godbey, WTVolume:
3
Year:
2016
Language:
english
Journal:
Molecular Therapy - Oncolytics
DOI:
10.1038/mto.2016.4
File:
PDF, 1.44 MB
english, 2016